Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00960505 · ClinicalTrials.gov registry record · NA

Alternate Day Fasting for Weight Loss, Weight Maintenance and Cardio-protection

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT00960505 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00960505, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The proposed research will demonstrate that alternate day modified fasting (ADMF) is a suitable alternative to daily calorie restriction (CR) for weight loss, weight maintenance, and heart disease prevention. Since many overweight and obese individuals find it difficult to adhere to daily CR, this diet option may improve adherence with these dietary restriction protocols. This, in turn, will allow a greater percent of the overweight and obese population to lose weight, maintain weight loss, and prevent future occurrences of coronary heart disease.

Interventions

  • OTHER Calorie restriction
  • OTHER Alternate day fasting
  • OTHER Control diet

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2010-09
Est. Completion 2015-01
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT00960505

The ClinicalTrials.gov registry entry for NCT00960505 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Calorie restriction is the first listed.

NCT00960505 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00960505 about?

NCT00960505 is a clinical study titled "Alternate Day Fasting for Weight Loss, Weight Maintenance and Cardio-protection". The proposed research will demonstrate that alternate day modified fasting (ADMF) is a suitable alternative to daily calorie restriction (CR) for weight loss, weight maintenance, and heart disease prevention. Since many overweight and obese individuals find it difficult to adhere to daily CR, this d...

What is the current status of trial NCT00960505?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2010-09. Estimated completion is 2015-01.

What interventions are being tested in trial NCT00960505?

The interventions under investigation include: Calorie restriction (OTHER), Alternate day fasting (OTHER), Control diet (OTHER).

Who is sponsoring clinical trial NCT00960505?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.